Publications
Publications
- 2021
- HBS Working Paper Series
Cephalosporins: Case Histories of Significant Medical Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
Abstract
Our case history describes the development of three generations of cephalosporins—antibiotics that have significantly reduced hospital infections. After providing an overview of antibiotic development and its challenges we describe how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th century, 2) Drug companies developed first-generation cephalosporins in the 1960s using foundational discoveries made by researchers in Italy and the UK in the 1940s and 1950s, and 3) Continued modifications of cephalosporin molecules resulted in second and third generations of the drugs in the 1970s and 1980s.
Keywords
Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Citation
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Cephalosporins: Case Histories of Significant Medical Advances." Harvard Business School Working Paper, No. 20-133, July 2020. (Revised May 2021.)
